NEW BRUNSWICK, N.J., Nov. 1 /PRNewswire/ -- Johnson & Johnson will
sponsor an analyst meeting and webcast for financial analysts on Thursday,
November 8, from 5:00-6:00 p.m. (Eastern Time) to coincide with the
American College of Rheumatology's annual meeting in Boston. The analyst
meeting will be held in the Republic Ballroom at the Sheraton Boston Hotel
located at 39 Dalton Street in Boston, approximately three miles from the
Convention and Exhibition Center where the ACR meeting is taking place.
The Company will discuss data being presented at ACR on three compounds
in its late-stage pharmaceutical pipeline: golimumab (CNTO 148),
ustekinumab (CNTO 1275), and tapentadol.
Joanne Waldstreicher, M.D., Global Head, Drug Development, CNS/Internal
Medicine Franchise, and Jay Siegel, M.D., Group President, Research &
Development, Biotech, Immunology & Oncology Franchise, will host the
meeting.
A webcast will be available through http://www.jnj.com. Please click on
the webcast icon for further instructions.
A webcast and podcast replay will be available approximately two hours
after the live event at http://www.jnj.com. Please click on
"Webcasts/Presentations" in the Investor Relations section of the site.
SOURCE Johnson & Johnson
 back to top
Related links:
http://www.jnj.com/
http://www.prnewswire.com/comp/467347.html/
CONTACT:
Jeffrey J. Leebaw, +1-732-524-3350, or Bill
Price, +1-732-524-6623, or Investors, Louise Mehrotra,
+1-732-524-6491, or Lesley Fishman, +1-732-524-3922, or Tina
Pinto, +1-732-524-2034, all of Johnson & Johnson
|
